NASDAQ:AFIB

Acutus Medical (AFIB) Stock Price, News & Analysis

$0.17
0.00 (0.00%)
(As of 04/23/2024 ET)
Today's Range
$0.17
$0.17
50-Day Range
$0.16
$0.26
52-Week Range
$0.16
$1.09
Volume
109,544 shs
Average Volume
1.92 million shs
Market Capitalization
$5.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AFIB stock logo

About Acutus Medical Stock (NASDAQ:AFIB)

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.

AFIB Stock Price History

AFIB Stock News Headlines

Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
See More Headlines
Receive AFIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
4/23/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:AFIB
Employees
230
Year Founded
2011

Profitability

Net Income
$-81,660,000.00
Net Margins
-166.79%
Pretax Margin
-165.52%

Debt

Sales & Book Value

Annual Sales
$7.16 million
Book Value
($0.03) per share

Miscellaneous

Free Float
28,676,000
Market Cap
$5.00 million
Optionable
Optionable
Beta
0.19

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Takeo Mukai (Age 43)
    CEO & CFO
  • Mr. Gary W. Doherty (Age 58)
    Senior Vice President of Finance
    Comp: $434.32k

AFIB Stock Analysis - Frequently Asked Questions

How have AFIB shares performed in 2024?

Acutus Medical's stock was trading at $0.2019 at the beginning of 2024. Since then, AFIB stock has decreased by 16.6% and is now trading at $0.1683.
View the best growth stocks for 2024 here
.

Are investors shorting Acutus Medical?

Acutus Medical saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 845,200 shares, a drop of 14.2% from the March 15th total of 984,700 shares. Based on an average daily volume of 2,250,000 shares, the short-interest ratio is presently 0.4 days. Currently, 4.5% of the shares of the company are short sold.
View Acutus Medical's Short Interest
.

When is Acutus Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our AFIB earnings forecast
.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) released its quarterly earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.92) by $0.02. The company earned $4.60 million during the quarter, compared to analysts' expectations of $6.02 million. Acutus Medical had a negative net margin of 166.79% and a negative trailing twelve-month return on equity of 35.31%. During the same quarter in the prior year, the firm earned ($1.18) EPS.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO).

When did Acutus Medical IPO?

Acutus Medical (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Acutus Medical have any subsidiaries?
The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..
Read More
This page (NASDAQ:AFIB) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners